Impact of Common Treatments Given in the Perinatal Period on the Developing Brain | Zendy

Géraldine Favrais | Zendy; Pierre Tourneux | Zendy; Emmanuel López | Zendy; Xavier Durrmeyer | Zendy; Géraldine Gascoin | Zendy; Duksha Ramful | Zendy; Elodie ZanaTaïeb | Zendy; Olivier Baud | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Impact of Common Treatments Given in the Perinatal Period on the Developing Brain

Author(s) -

Géraldine Favrais,

Pierre Tourneux,

Emmanuel López,

Xavier Durrmeyer,

Géraldine Gascoin,

Duksha Ramful,

Elodie ZanaTaïeb,

Olivier Baud

Publication year - 2014

Publication title -

neonatology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.399

H-Index - 84

eISSN - 1661-7819

pISSN - 1661-7800

DOI - 10.1159/000363492

Subject(s) - medicine , neuroprotection , brain damage , neurocognitive , pediatrics , periventricular leukomalacia , intensive care medicine , anesthesia , pregnancy , gestational age , cognition , psychiatry , biology , genetics

Over the last decades, considerable progress has been made in the perinatal management of high-risk preterm neonates, changing the landscape of pathological conditions associated with neurological impairments. Major focal destructive lesions are now less common, and the predominant neuropathological lesion is diffuse white-matter damage in the most immature infants. Similarly, over the last few years, we have observed a trend towards a decrease in neurological impairment in the absence of treatments specifically aimed at neuroprotection.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research